Yvonne O’Meara

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Expression of Gremlin, a Bone Morphogenetic Protein Antagonist, in Human Diabetic Nephropathy

Vincent Dolan, Madeline Murphy, Denise M. Sadlier et al. · American Journal of Kidney Diseases · 2005 · 136 citations · Full text

Medicine, Molecular Biology, Nephrology +13

Physical function, employment and quality of life in end-stage renal disease.

Catherine Blake, Mary Codd, Aedín Cassidy et al. · PubMed · 2000 · 130 citations

Medicine, Internal Medicine, Nephrology +14

Allelic Depletion of <i>grem1</i> Attenuates Diabetic Kidney Disease

Sarah Roxburgh, Jayesh J. Kattla, Simon P. Curran et al. · Diabetes · 2009 · 80 citations · Full text

Medicine, Genetics, Molecular Biology +17

Acute renal failure due to lymphomatous infiltration of the kidneys.

Gregorio T. Obrador, Barbara Price, Yvonne O’Meara et al. · Journal of the American Society of Nephrology · 1997 · 78 citations

Medicine, Nephrology, Oncology +17